Cezmi Akdis

Cezmi Akdis is the director of the Swiss Institute of Allergy and Asthma Research (SIAF) in Davos and Ordinarius Professor in Zurich University Medical Faculty. Cezmi Akdis acted as the President of the European Academy of Allergy & Clinical Immunology (15’000 members) between 2011-2013. He was the editor of Global Atlases of Allergy, Asthma I-II, Chronic Rhinosinusitis and Allergic Rhinitis.

He was the founder and organizer of the World Immune Regulation Meetings, Davos I-XVI (600-1000 participants).

Cezmi Akdis has published more than 650 peer-reviewed articles. His h-index is 115 (Web of Science) and 140 (Google Scholar) and he was selected as a highly cited author consecutively in 2016-2017-2018-2019-2020 and 2021 by Clarivate (Thomson Reuters).

He is currently the Editor-in-Chief of the Allergy journal, impact factor 14.71. Cezmi Akdis’s major scientific contributions are on immune regulation and allergen tolerance, plasticity of antigen-specific T cells, T regulatory cells 1995-, immune suppressive role of histamine receptor 2 2000, human Type 2 and regulatory NK cells 2002-2007, regulatory innate B cell subset 2017, regulatory innate lymphoid cells 2019. His current research is the continuation of his epithelial barrier hypothesis studies starting from mechanisms of eczema 2000, mechanisms of epithelial shedding in asthma and chronic rhinosinusitis 2003, endotypes of asthma, chronic rhinosinusitis and atopic dermatitis 2011, epithelial barrier hypothesis for the development of allergic and autoimmune diseases 2015 - 2022. Cezmi Akdis is the author of more than 40 publications on COVID including one of the first ones published on 19 February 2020.